id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0614-0005,FDA,FDA-2008-D-0614,Guidance for Industry on Changes to Approved New Animal Drug Applications-New Animal Drug Applications Versus Category II SupplementalNew Animal Drug Applications; Availability,Other,GDL-Guidance (Supporting and Related Materials),2009-11-20T05:00:00Z,2009,11,2009-11-20T05:00:00Z,,2024-11-07T22:11:05Z,,1,0,0900006480a5b9b0
FDA-2008-D-0614-0004,FDA,FDA-2008-D-0614,Guidance for Industry on Changes to Approved New Animal Drug Applications-New Animal Drug Applications Versus Category II SupplementalNew Animal Drug Applications; Availability,Notice,NAD-Notice of Availability of Data,2009-11-20T05:00:00Z,2009,11,2009-11-20T05:00:00Z,,2024-11-07T22:11:17Z,E9-27926,1,0,0900006480a5b4d9
FDA-2008-D-0614-0002,FDA,FDA-2008-D-0614,Guidance for Industry Changes to Approved NADAs - New NADAs vs. Category II Supplemental NADAs - Guidance,Supporting & Related Material,GDL-Guidance,2008-12-16T05:00:00Z,2008,12,,,2008-12-20T16:30:41Z,,0,0,09000064807ddbba
FDA-2008-D-0614-0001,FDA,FDA-2008-D-0614,Draft Guidance for Industry on Changes to Approved New Animal Drug Applications--New Animal Drug Applications Versus Category II Supplemental New Animal Drug Applications; Availability,Notice,NAD-Notice of Availability of Data,2008-12-16T05:00:00Z,2008,12,2008-12-16T05:00:00Z,2009-02-18T04:59:59Z,2008-12-20T16:30:42Z,E8-29691,0,0,09000064807dd83e